Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Molina

Showing results (571-580 of 647) with videos related to

Pageof 65
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.
Frontiers in Oncology|April 9, 2020
Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution ExperienceWilliam G Breen, Yolanda I Garces, Kenneth R Olivier, et al.
Journal of Environmental Management|January 4, 2026
Protected areas influence fire regimes globallyA Cardil, M Rodrigues, D Ascoli, et al.
The Oncologist|November 11, 2018
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical TrialsNarjust Duma, Sejal M Kothadia, Tariq U Azam, et al.
Medicina Intensiva|November 26, 2009
[Managing the post-cardiac arrest syndrome. Directing Committee of the National Cardiopulmonary Resuscitation Plan (PNRCP) of the Spanish Society for Intensive Medicine, Critical Care and Coronary Units (SEMICYUC)]H Martín-Hernández, J B López-Messa, J L Pérez-Vela, et al.
Bone Marrow Transplantation|August 4, 2012
Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALLJ Sanchez-Garcia, J Serrano, J Serrano-Lopez, et al.
Translational Lung Cancer Research|March 15, 2021
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinomaXuefeng Leng, Shiyou Wei, Jiandong Mei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancerJennifer B Dennison, Jennifer R Molina, Shreya Mitra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2012
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528Grace K Dy, Sumithra J Mandrekar, Garth D Nelson, et al.
Immunohorizons|July 11, 2022
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic ResponseAlex M Eddie, Kevin W Chen, Laurie B Schenkel, et al.
Pageof 65

Showing results (571-580 of 647) with videos related to

Sort By:
Pageof 65
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.
Frontiers in Oncology|April 9, 2020
Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution ExperienceWilliam G Breen, Yolanda I Garces, Kenneth R Olivier, et al.
Journal of Environmental Management|January 4, 2026
Protected areas influence fire regimes globallyA Cardil, M Rodrigues, D Ascoli, et al.
The Oncologist|November 11, 2018
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical TrialsNarjust Duma, Sejal M Kothadia, Tariq U Azam, et al.
Medicina Intensiva|November 26, 2009
[Managing the post-cardiac arrest syndrome. Directing Committee of the National Cardiopulmonary Resuscitation Plan (PNRCP) of the Spanish Society for Intensive Medicine, Critical Care and Coronary Units (SEMICYUC)]H Martín-Hernández, J B López-Messa, J L Pérez-Vela, et al.
Bone Marrow Transplantation|August 4, 2012
Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALLJ Sanchez-Garcia, J Serrano, J Serrano-Lopez, et al.
Translational Lung Cancer Research|March 15, 2021
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinomaXuefeng Leng, Shiyou Wei, Jiandong Mei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancerJennifer B Dennison, Jennifer R Molina, Shreya Mitra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2012
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528Grace K Dy, Sumithra J Mandrekar, Garth D Nelson, et al.
Immunohorizons|July 11, 2022
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic ResponseAlex M Eddie, Kevin W Chen, Laurie B Schenkel, et al.
Pageof 65